Amidst the recent COVID-19 pandemic, countries are reviving rarely used legislation to ensure that COVID-19 related medicines which could potentially be used against the Coronavirus are available. Will South Africa join the chorus of countries limiting patent rights on Coronavirus-related medicine?
